Related Experiment Videos

Matrix metalloproteinases and metalloproteinase inhibitors in choroidal neovascular membranes

B Steen1, S Sejersen, L Berglin

  • 1Department of Ophthalmology, St. Erik's Eye Hospital, Karolinska Institute, Stockholm, Sweden.

Abstract

Insights

Matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinases (TIMP) are involved in choroidal neovascularization in age-related macular degeneration (AMD). MMP-2 and MMP-9 were detected in membranes, suggesting a role in AMD progression.

Area of Science:

  • Ophthalmology
  • Molecular Biology
  • Cell Biology

Background:

  • Matrix metalloproteinases (MMPs) are enzymes that degrade extracellular matrix.
  • MMPs are implicated in neovascularization, a process involved in age-related macular degeneration (AMD).

Purpose of the Study:

  • To investigate the role of MMPs and TIMPs in choroidal neovascularization in AMD.
  • Analyze mRNA expression of MMPs and TIMPs in subfoveal fibrovascular membranes from AMD patients.

Main Methods:

  • Surgically removed subfoveal fibrovascular membranes from five AMD eyes were analyzed.
  • In situ hybridization was used to detect mRNA expression of MMP-1, MMP-2, MMP-3, MMP-9, TIMP-1, TIMP-2, and TIMP-3.
  • Immunostaining for von Willebrand factor identified vascular endothelial cells.

Main Results:

  • MMP-2 and MMP-9 mRNA were detected in all analyzed membranes.
  • TIMP-1 and TIMP-3 mRNA were present in most membranes; TIMP-2 mRNA was found in two.
  • MMP-2 localized to vascular endothelial cells, while MMP-9 was found at membrane margins.

Conclusions:

  • Results support a role for MMPs in choroidal neovascularization development in AMD.
  • MMP-2 and MMP-9 localization suggests cooperative involvement in the growth of choroidal neovascular membranes in AMD.

Related Concept Videos